Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Bouchard (1995)
Genetics and the metabolic syndrome.International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 19 Suppl 1
B. Desbuquois, G. Aurbach (1971)
Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays.The Journal of clinical endocrinology and metabolism, 33 5
Y. Bossé, J. Despres, C. Bouchard, L. Pérusse, M. Vohl (2003)
The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.Obesity research, 11 7
C. Laurell (1966)
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.Analytical biochemistry, 15 1
P. Costet, C. Legendre, J. Moré, A. Edgar, P. Galtier, T. Pineau (1998)
Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis*The Journal of Biological Chemistry, 273
S. Moorjani, A. Dupont, F. Labrie, P. Lupien, D. Brun, C. Gagné, M. Giguère, A. Bélanger (1987)
Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.Metabolism: clinical and experimental, 36 3
A. Sapone, J. Peters, S. Sakai, S. Tomita, S. Papiha, R. Dai, F. Friedman, F. Gonzalez (2000)
The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.Pharmacogenetics, 10 4
J. Mcnamara, E. Schaefer (1987)
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions.Clinica chimica acta; international journal of clinical chemistry, 166 1
K. Motojima (2000)
Differential effects of PPARalpha activators on induction of ectopic expression of tissue-specific fatty acid binding protein genes in the mouse liver.The international journal of biochemistry & cell biology, 32 10
R. Havel, H. Eder, J. Bragdon (1955)
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.The Journal of clinical investigation, 34 9
T. Aoyama, J. Peters, N. Iritani, T. Nakajima, K. Furihata, T. Hashimoto, F. Gonzalez (1998)
Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)*The Journal of Biological Chemistry, 273
O. Braissant, Fabienne Foufelle, C. Scotto, M. Dauça, W. Wahli (1996)
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 137 1
C. Lacquemant, F. Leprêtre, I. Torra, M. Manraj, G. Charpentier, J. Ruiz, B. Staels, P. Froguel (2000)
Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease.Diabetes & metabolism, 26 5
B. Frohnert, T. Hui, D. Bernlohr (1999)
Identification of a Functional Peroxisome Proliferator-responsive Element in the Murine Fatty Acid Transport Protein Gene*The Journal of Biological Chemistry, 274
G. Chinetti, Franck Gbaguidi, S. Griglio, Z. Mallat, Micheline Antonucci, P. Poulain, J. Chapman, J. Fruchart, A. Tedgui, Jamila Najib-Fruchart, B. Staels (2000)
CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.Circulation, 101 20
G. Reaven (1988)
Role of Insulin Resistance in Human DiseaseDiabetes, 37
D. Flavell, I. Torra, Y. Jamshidi, D. Evans, J. Diamond, R. Elkeles, S. Bujac, G. Miller, P. Talmud, B. Staels, S. Humphries (2000)
Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjectsDiabetologia, 43
M. Vohl, P. Lepage, D. Gaudet, C. Brewer, C. Bétard, P. Perron, G. Houde, Christine Cellier, J. Faith, J. Despres, K. Morgan, T. Hudson (2000)
Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia.Journal of lipid research, 41 6
S. Grundy, H. Brewer, J. Cleeman, Sidney Smith, C. Lenfant, R. Bonow, R. Eckel, D. Einhorn, S. Haffner, R. Holman, E. Horton, R. Krauss, Daniel Levy, X. Pi-Sunyer, D. Porte, G. Reaven, F. Sacks, N. Stone, P. Wilson (2004)
Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to DefinitionCirculation: Journal of the American Heart Association, 109
P. Kris-Etherton, S. Daniels, R. Eckel, Engler Mm, B. Howard, R. Krauss, A. Lichtenstein, F. Sacks, S. Jeor, M. Stampfer, S. Grundy, L. Appel, T. Byers, H. Campos, G. Cooney, M. Denke, Eileen Kennedy, P. Marckmann, T. Pearson, G. Riccardi, L. Rudel, M. Rudrum, F. Sacks, Daniel Stein, R. Tracy, V. Ursin, R. Vogel, P. Zock, T. Bazzarre, J. Clark (2001)
AHA scientific statement: Summary of the scientific conference on dietary fatty acids and cardiovascular healthJournal of Nutrition, 131
M. Burstein, J. Samaille (1960)
Sur un dosage rapide du cholesterol lié aux α-et aux β-lipoprotéines du sérumClinica Chimica Acta, 5
I. Torra, P. Gervois, B. Staels (1999)
Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.Current opinion in lipidology, 10 2
C. Mascaró, E. Acosta, J. Ortiz, P. Marrero, F. Hegardt, D. Haro (1998)
Control of Human Muscle-type Carnitine Palmitoyltransferase I Gene Transcription by Peroxisome Proliferator-activated Receptor*The Journal of Biological Chemistry, 273
K. Schoonjans, B. Staels, J. Auwerx (1996)
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.Biochimica et biophysica acta, 1302 2
B. Staels, J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, J. Fruchart (1998)
Mechanism of action of fibrates on lipid and lipoprotein metabolism.Circulation, 98 19
R. Richterich, H. Dauwalder (1971)
[Determination of plasma glucose by hexokinase-glucose-6-phosphate dehydrogenase method].Schweizerische medizinische Wochenschrift, 101 17
H.E. Xu, M. Lambert, V. Montana, D. Parks, S. Blanchard, P. Brown, D. Sternbach, J. Lehmann, G. Wisely, T. Willson, S. Kliewer, M. Milburn (2000)
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors.Molecular cell, 3 3
W. Friedewald, R. Levy, D. Fredrickson (1972)
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clinical chemistry, 18 6
K. Schoonjans, B. Staels, J. Auwerx (1996)
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.Journal of lipid research, 37 5
J. Auwerx, E. Baulieu, M. Beato, M. Becker‐André, P. Burbach, G. Camerino, P. Chambon, A. Cooney, A. Dejean, C. Dreyer, R. Evans, F. Gannon, V. Giguère, H. Gronemeyer, J. Gustafsson, V. Laudet, M. Lazar, D. Mangelsdorf, J. Millbrandt, E. Milgrom, D. Moore, B. O’Malley, M. Parker, K. Parker, T. Perimann, M. Pfahl, M. Rosenfeld, H. Samuels, G. Schütz, F. Sladek, H. Stunnenberg, M. Spedding, C. Thummel, M. Tsai, K. Umesono, B. Vennstrom, W. Wahli, C. Weinberg, T. Willson, K. Yamamoto (1999)
A Unified Nomenclature System for the Nuclear Receptor SuperfamilyCell, 97
D. Auboeuf, J. Rieusset, L. Fajas, P. Vallier, V. Frering, J. Riou, B. Staels, J. Auwerx, M. Laville, H. Vidal (1997)
Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM PatientsDiabetes, 46
T. Osumi, J. Wen, T. Hashimoto (1991)
Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene.Biochemical and biophysical research communications, 175 3
S. Grundy, B. Hansen, Sidney Smith, J. Cleeman, R. Kahn (2004)
Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to ManagementCirculation: Journal of the American Heart Association, 109
E. Tai, S. Demissie, L. Cupples, Dolores Corella, P. Wilson, E. Schaefer, J. Ordovás (2002)
Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels: The Framingham Offspring StudyArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 22
M. Guerre-Millo, P. Gervois, E. Raspé, L. Madsen, P. Poulain, B. Derudas, J. Herbert, D. Winegar, T. Willson, J. Fruchart, R. Berge, B. Staels (2000)
Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity*The Journal of Biological Chemistry, 275
J. Lehmann, J. Lenhard, B. Oliver, G. Ringold, S. Kliewer (1997)
Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs*The Journal of Biological Chemistry, 272
G. Krey, O. Braissant, F. L'horset, E. Kalkhoven, M. Perroud, M. Parker, W. Wahli (1997)
Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay.Molecular endocrinology, 11 6
E. Ford, W. Giles, W. Dietz (2002)
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.JAMA, 287 3
Genetic factors, alone or in interaction with components of the diet, are thought to be involved in the development of the metabolic syndrome. The objective of our study was first to compare the frequency of the peroxisome proliferator-activated receptor (PPAR)α-L162V polymorphism in a sample of men with and without the metabolic syndrome as defined by the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATPIII) guidelines, and secondly, to evaluate gene–diet interaction effects on features of the metabolic syndrome. The PPARα-L162V genotype was determined in a sample of 632 men by a polymerase chain reaction–restriction length polymorphism (PCR–RFLP)-based method; fat as well as saturated fat intakes were evaluated by a dietitian-administered food frequency questionnaire. The frequency of the V162 allele was similar in men with (n=281) and without (n=351) the metabolic syndrome (χ 2=0.03, p=0.84) but was higher in subjects having simultaneously abdominal obesity, hypertriglyceridemia, and low high-density lipoprotein cholesterol (HDL-C) levels (χ 2=3.73, p=0.05). Carriers of the V162 were characterized by higher plasma apolipoprotein B and triglyceride (TG) levels (p=0.10, p=0.004). In a model including the PPARα-L162V polymorphism, fat or saturated fat, its interaction, and covariates (smoking habits, and energy and alcohol intake), the interaction explained a significant percentage of the variance observed in waist circumference (p<0.05). In conclusion, the PPARα-L162V polymorphism alone or in interaction with dietary fat intake is associated with components of the metabolic syndrome.
Journal of Human Genetics – Springer Journals
Published: Aug 10, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.